Shanghai, China

Yuan-zhi Lao

This inventor holds 1 USPTO granted patent. Top assignee: Hong Kong Baptist University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuan-zhi Lao. Retrieved from https://idiyas.com/inventor/yuan-zhi-lao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment: The Contributions of Inventor Yuan-zhi Lao

Introduction: Yuan-zhi Lao is an innovative inventor based in Shanghai, China, renowned for his significant contributions to the field of cancer research. Holding one patent, he has demonstrated a commitment to advancing medical science through his inventive work.

Latest Patents: Yuan-zhi Lao's most notable patent involves a compound extracted from specific species, which has shown promising potential in the prevention and treatment of cancer. This innovation reflects his dedication to addressing critical health challenges through scientific research and development.

Career Highlights: As a member of Hong Kong Baptist University, Yuan-zhi Lao has been instrumental in conducting research that bridges the gap between academia and practical medical applications. His career has been marked by a deep engagement with innovative methodologies aimed at combating cancer, showcasing his expertise and dedication.

Collaborations: In his pursuits, Yuan-zhi Lao has collaborated with esteemed colleagues, including Hong-xi Xu and Zhi-jie Ding. Together, this team has worked diligently to enhance the understanding of cancer therapeutics and develop effective solutions.

Conclusion: Yuan-zhi Lao's work exemplifies the impact that dedicated inventors can have on healthcare innovation. Through his patent and collaborative efforts, he continues to contribute to vital advancements that may change the landscape of cancer treatment and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…